ATE397751T1 - Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheiten - Google Patents
Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheitenInfo
- Publication number
- ATE397751T1 ATE397751T1 AT04707898T AT04707898T ATE397751T1 AT E397751 T1 ATE397751 T1 AT E397751T1 AT 04707898 T AT04707898 T AT 04707898T AT 04707898 T AT04707898 T AT 04707898T AT E397751 T1 ATE397751 T1 AT E397751T1
- Authority
- AT
- Austria
- Prior art keywords
- diseases
- diagnostics
- disorders
- ht1f
- therapy methods
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 5
- 101710138086 5-hydroxytryptamine receptor 1F Proteins 0.000 title abstract 2
- 102100036311 5-hydroxytryptamine receptor 1F Human genes 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 230000002489 hematologic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 208000035475 disorder Diseases 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000012931 Urologic disease Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 210000003169 central nervous system Anatomy 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 210000003205 muscle Anatomy 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 210000001428 peripheral nervous system Anatomy 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000014001 urinary system disease Diseases 0.000 abstract 2
- 101000783605 Homo sapiens 5-hydroxytryptamine receptor 1F Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03003538 | 2003-02-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE397751T1 true ATE397751T1 (de) | 2008-06-15 |
Family
ID=32864942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04707898T ATE397751T1 (de) | 2003-02-17 | 2004-02-04 | Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheiten |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060234240A1 (de) |
| EP (1) | EP1597589B1 (de) |
| AT (1) | ATE397751T1 (de) |
| DE (1) | DE602004014254D1 (de) |
| ES (1) | ES2306983T3 (de) |
| WO (1) | WO2004072651A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2959904A1 (de) | 2014-06-27 | 2015-12-30 | Institut De Recerca Contra La Leucemia Josep Carreras | Verfahren zur Behandlung, Diagnose und Prognose einer hämatologischen Malignität |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406859B1 (en) * | 1992-01-08 | 2002-06-18 | Synaptic Pharmaceutical Corporation | DNA encoding a 5-HT 1F receptor and uses thereof |
| US5360735A (en) * | 1992-01-08 | 1994-11-01 | Synaptic Pharmaceutical Corporation | DNA encoding a human 5-HT1F receptor, vectors, and host cells |
| DE69434492T2 (de) * | 1993-03-10 | 2006-07-13 | Smithkline Beecham Corp. | Phosphodiesterase des menschlichen gehirns |
| US5968817A (en) * | 1993-03-15 | 1999-10-19 | The Scripps Research Institute | DNA encoding serotonin receptors |
| WO2003039476A2 (en) * | 2001-11-07 | 2003-05-15 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
-
2004
- 2004-02-04 AT AT04707898T patent/ATE397751T1/de not_active IP Right Cessation
- 2004-02-04 WO PCT/EP2004/000995 patent/WO2004072651A2/en not_active Ceased
- 2004-02-04 EP EP04707898A patent/EP1597589B1/de not_active Expired - Lifetime
- 2004-02-04 ES ES04707898T patent/ES2306983T3/es not_active Expired - Lifetime
- 2004-02-04 US US10/545,463 patent/US20060234240A1/en not_active Abandoned
- 2004-02-04 DE DE602004014254T patent/DE602004014254D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2306983T3 (es) | 2008-11-16 |
| WO2004072651A2 (en) | 2004-08-26 |
| WO2004072651A3 (en) | 2004-10-28 |
| DE602004014254D1 (de) | 2008-07-17 |
| EP1597589A2 (de) | 2005-11-23 |
| EP1597589B1 (de) | 2008-06-04 |
| US20060234240A1 (en) | 2006-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005093092A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44) | |
| WO2004042389A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
| WO2003093816A3 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
| WO2003065046A3 (en) | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor | |
| EP2017620A3 (de) | Diagnostika und Therapeutika für mit Dipeptidyl-peptidase 1 (DPP1) assoziierten Krankheiten | |
| WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
| ATE412903T1 (de) | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten | |
| ATE397751T1 (de) | Diagnostik- und therapie- verfahren von mit 5- ht1f rezeptor verbundenen haematologischen krankheiten | |
| WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
| ATE554393T1 (de) | Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen | |
| WO2003065044A8 (en) | Diagnostics and therapeutics for diseases associated with gpr72 | |
| DE602004014261D1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten | |
| WO2003100435A3 (en) | Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) | |
| WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
| WO2003066077A3 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
| WO2004071394A3 (en) | Diagnostics and therapeutics for diseases associated with hm74 | |
| WO2003100434A3 (en) | Diagnostic and therapeutic use of the arginine vasopressin receptor 2 (avpr2) | |
| WO2004038421A3 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
| DE602004013770D1 (de) | Diagnostik- und therapie- verfahren von mit pils verbundenen krankheiten | |
| WO2004071393A3 (en) | Diagnostics and therapeutics for diseases associated with glucagon-like peptide 1 receptor (glp1r) | |
| WO2004050903A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
| WO2003100433A3 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
| WO2005101009A3 (en) | Diagnostics and therapeutics for diseases associated with tachykinin receptor 2 (tacr2) | |
| WO2006013014A3 (en) | Diagnostics and therapeutics for diseases associated with prostate-specific membrane antigen-like protein (psmal) | |
| WO2004015427A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |